Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • Peer reviewer login
    • WoS Reviewer Recognition Service
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • Peer reviewer login
    • WoS Reviewer Recognition Service
  • Alerts
  • Subscriptions

“Safety of nintedanib added to pirfenidone treatment for idiopathic pulmonary fibrosis.” Kevin R. Flaherty, Charlene D. Fell, J. Terrill Huggins, Hilario Nunes, Robert Sussman, Claudia Valenzuela, Ute Petzinger, John L. Stauffer, Frank Gilberg, Monica Bengus and Marlies Wijsenbeek. Eur Respir J 2018; 52: 1800230.

European Respiratory Journal 2018 52: 1850230; DOI: 10.1183/13993003.50230-2018
  • Article
  • Info & Metrics
  • PDF
Loading

This article from the August 2018 issue of the European Respiratory Journal was originally published in a form omitting an acknowledgement of additional investigators involved with the study. The article has been corrected and republished online, with the following list of investigators added.

List of investigators: Charlene D. Fell (Calgary, Canada), Shane Shapera (Toronto, Canada), Saher B. Shaker (Hellerup, Denmark), Vincent Cottin (Bron, France), Stephane Jouneau (Rennes, France), Hilario Nunes (Bobigny, France), Francesco Tommaso Bonella (Essen, Germany), Dirk Koschel (Coswig, Germany), Philipp Markart (Fulda, Germany), Carlo Albera (Orbassano, Italy), Alberto Pesci (Monza, Italy), Paola Rottoli (Siena, Italy), Laura Tavanti (Cisanello, Italy), Marcel Veltkamp (Nieuwegein, The Netherlands), Marlies Wijsenbeek (Rotterdam, The Netherlands), Orlando Acosta (La Laguna, Spain), Elena Bollo (León, Spain), Alvaro Casanova Espinosa (Madrid, Spain), Juan Gustavo (Valencia, Spain), Maria Molina-Molina (Barcelona, Spain), Jose A. Rodriguez-Portal (Seville, Spain), Claudia Valenzuela (Madrid, Spain), John Belperio (Los Angeles, CA, USA), John Butler (Portland, OR, USA), Sakshi Dua (New York, NY, USA), Kevin R. Flaherty (Ann Arbor, MI, USA), Todd Horiuchi (Sarasota, FL, USA), J. Terrill Huggins (Charleston, SC, USA), Gaurav Khanna (Cincinnati, OH, USA), Christopher King (Falls Church, VA, USA), Andrew Labelle (Chesterfield, MO, USA), Lisa H. Lancaster (Nashville, TN, USA), Joshua Mooney (Stanford, CA, USA), Lee Morrow (Omaha, NE, USA), Nina Patel (New York, NY, USA), Murali Ramaswamy (Greensboro, NC, USA), Robert Sussman (Springfield, NJ, USA), Joseph Zibrak (Boston, MA, USA).

  • Copyright ©ERS 2018
PreviousNext
Back to top
View this article with LENS
Vol 52 Issue 4 Table of Contents
European Respiratory Journal: 52 (4)
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
“Safety of nintedanib added to pirfenidone treatment for idiopathic pulmonary fibrosis.” Kevin R. Flaherty, Charlene D. Fell, J. Terrill Huggins, Hilario Nunes, Robert Sussman, Claudia Valenzuela, Ute Petzinger, John L. Stauffer, Frank Gilberg, Monica Be…
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
“Safety of nintedanib added to pirfenidone treatment for idiopathic pulmonary fibrosis.” Kevin R. Flaherty, Charlene D. Fell, J. Terrill Huggins, Hilario Nunes, Robert Sussman, Claudia Valenzuela, Ute Petzinger, John L. Stauffer, Frank Gilberg, Monica Bengus and Marlies Wijsenbeek. Eur Respir J 2018; 52: 1800230.
European Respiratory Journal Oct 2018, 52 (4) 1850230; DOI: 10.1183/13993003.50230-2018

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
“Safety of nintedanib added to pirfenidone treatment for idiopathic pulmonary fibrosis.” Kevin R. Flaherty, Charlene D. Fell, J. Terrill Huggins, Hilario Nunes, Robert Sussman, Claudia Valenzuela, Ute Petzinger, John L. Stauffer, Frank Gilberg, Monica Bengus and Marlies Wijsenbeek. Eur Respir J 2018; 52: 1800230.
European Respiratory Journal Oct 2018, 52 (4) 1850230; DOI: 10.1183/13993003.50230-2018
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
  • Info & Metrics
  • PDF
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • “Interstitial lung abnormalities are associated with decreased mean telomere length.” R.K. Putman, G.T. Axelsson, S.Y. Ash, et al. Eur Respir J 2022; 60: 2101814
  • “Impact of hepatopulmonary syndrome in liver transplantation candidates and the role of angiogenesis.” S.M. Kawut, M.J. Krowka, K.A. Forde, N. Al-Naamani, K.L. Krok, M. Patel, C.R. Bartoli, M. Doyle, J. Moutchia, G. Lin, J.K. Oh, C.D. Mottram, P.D. Scanlon and M.B. Fallon for the Pulmonary Vascular Complications of Liver Disease Study Group. Eur Respir J 2022; 60: 2102304.
  • “Gut microbiota mediate vascular dysfunction in a murine model of sleep apnoea: effect of probiotics.” M. Badran, A. Khalyfa, A.C. Ericsson, C. Puech, Z. McAdams, S.B. Bender and D. Gozal. Eur Respir J 2023; 61: 2200002.
Show more Author Correction

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society